And while many assume the answer is to just stop the GLP-1, the majority of time thats not a realistic option
WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy
However, its important to realize that these results depend on several factors, including your starting weight and age, lifestyle changes (especially diet and exercise habits), and adherence to the treatment plan
Retatrutide: The benchmark for weight loss Retatrutide, produced by Eli Lilly, also activates glucagon receptors, alongside GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, which helps regulate blood glucose and nutrient balance (leading to the drug being dubbed the triple G for activating these three receptors)
Increasing exercise endurance - L-carnitine carries fatty acids into our cells mitochondria where they can be burnt and used for energy